FMF & AID Global Association
EULAR recommendations for the management of FMF
Familial Mediterranean fever with a single MEFV mutation: where is the Second hit?
Colchicine brand switching.
Canakinumab controls periodic fever syndromes in post-flare and maintenance dosing.
Concordance between CRP and SAA in familial Mediterranean fever during attack-free period.
VIB scientists develop diagnostic tool for Familial Mediterranean Fever.
Vitamin D levels in children with familial Mediterranean Fever.
Colchicine fast acting
Primary headaches in pediatric patients with chronic rheumatic disease.
1st lab in Canada to offer amyloid testing.
Familial Mediterranean fever with a single MEFV mutation
Cannabis in kids
Familial Mediterranean fever with a single MEFV mutation: can a deletion resulting in a-thalassemia be the cause?
Mortality in FMF patients
Obesity caused by inflammation
Microbiota and gut-liver axis: a mini-review on their influences on obesity and obesity related liver disease
Colchicine trial in PFAPA Syndrome and MEFV-negative patients
Psoriasis and FMF
Kastner presentation on FMF
Ilaris also approved for FMF
Possible cure of fibromyalgia
Adult Cyclic Vomiting Syndrome Successfully Treated with Intranasal Sumatriptan
The Anemia of FMF disease
Colchicine and interaction with grapefruit
Seizures on FMF patients
Autoinflammatory disorders and treatment
Thoraxic and lung involvement in FMF
Exertional leg pain in FMF
Chronic inflammation in FMF (between attacks)
FMF without MEFV mutations
Higher Ilaris Doses Raise Response Rates in CAPS
Successful treatment with RoActemra (tocilizumab)
Comorbidities in patients with Familial Mediterranean Fever
Coconut oil for mouth ulcers
Successful treatment of familial Mediterranean fever with Anakinra and outcome after renal transplantation
The role of the inflammasome in patients with autoinflammatory diseases
Chronic inflammation in FMF: markers, risk factors, outcomes and therapy
EULAR recommendations for the management of Behçet disease
The schedule of administration of canakinumab in CAPS is driven by the phenotype severity rather than the age
Scylla and the myth of Familial Mediterranean Fever (Italian/English)
Anakinra as a diagnostic challenge and treatment option for systemic autoinflammatory disorders of undefined etiology
Development of the autoinflammatory disease damage index (ADDI)
Colchicine is a Safe Drug in Children with Familial Mediterranean Fever
Ehlers-Danlos syndrome hypermobility type is associated with rheumatic diseases
EUROFEVER classification criteria
New atopic dermatitis drug approved - Crisaborole (Eucrisa) phosphodiesterase-4 inhibitor, applied topically twice daily
Familial Mediterranean fever is no longer a rare disease in Japan
A single mutated MEFV allele in Israeli patients suffering from familial Mediterranean fever and Behçet's disease
Familial Mediterranean fever without MEFV mutations: a case–control study
Periodic Fever with Aphthous Stomatitis, Pharyngitis, and Cervical Adenitis Syndrome Is Associated with a CARD8 Variant Unable To Bind the NLRP3 Inflammasome
Exertional leg pain and spondyloarthropathy on FMF
Exertional leg pain in familial Mediterranean fever: a manifestation of an underlying enthesopathy and a marker of more severe disease
Non-periodic leg pain in patients with familial Mediterranean fever
Normal arterial stiffness in familial Mediterranean fever: evidence for a possible cardiovascular protective role of colchicine